Výsledky vyhledávání - Catherine Dubos‐Arvis

  • Zobrazuji výsledky 1 - 11 z 11
Upřesnit hledání
  1. 1
    Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients

    Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients Autor Charline Lasnon, Cédric Desmonts, Elske Quak, Radj Gervais, Pascal Dô, Catherine Dubos‐Arvis, Nicolas Aide

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC

    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC Autor Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

    Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018 Autor Florian Guisier, Catherine Dubos‐Arvis, F. Viñas, H. Doubre, Charles Ricordel, Stanislas Ropert, Henri Janicot, Massimo Bernardi, P. Fournel, R. Lamy, M. Pérol, Jérôme Dauba, Gilles Gonzales, L. Falchero, C. Decroisette, Pascal Assouline, C. Chouaïd, Olivier Bylicki

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

    Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO) Autor Marie Wislez, Julien Mazières, A. Lavolé, Gérard Zalcman, Olivier Carré, Thomas Egenod, Raffaele Caliandro, Catherine Dubos‐Arvis, G. Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin, Françoise Le Pimpec‐Barthes, L. Brouchet, Jalal Assouad, B. Milleron, Diane Damotte, Martine Antoine, Virginie Westeel

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Pembrolizumab (pembro) vs docetaxel (doce) for previously treated, PD-L1–expressing NSCLC: Updated outcomes of KEYNOTE-010

    Pembrolizumab (pembro) vs docetaxel (doce) for previously treated, PD-L1–expressing NSCLC: Updated outcomes of KEYNOTE-010 Autor Roy S. Herbst, Paul Baas, Dong‐Wook Kim, Enriqueta Felip, Jose Luis Pérez‐Gracia, J. Y. Han, Juan Pablo Molina, Jae‐Hun Kim, Catherine Dubos Arvis, M-J. Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Yue Shentu, Gregory M. Lubiniecki, E.B. Garon

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

    Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study Autor Roy S. Herbst, Edward B. Garon, Dong‐Wan Kim, Byoung Chul Cho, Jose Luis Pérez‐Gracia, Ji‐Youn Han, Catherine Dubos Arvis, Margarita Majem, Martin Förster, I. Monnet, Silvia Novello, Zsuzsanna Szalai, Matthew A. Gubens, Wu‐Chou Su, Giovanni Luca Ceresoli, Ayman Samkari, Erin Jensen, Gregory M. Lubiniecki, Paul Baas

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    PD1.06 (also presented as P2.41): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

    PD1.06 (also presented as P2.41): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment Autor Roy S. Herbst, Paul Baas, Jose Luis Pérez‐Gracia, Enriqueta Felip, Dong‐Wan Kim, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Veerle Surmont, Gilberto de Castro, Marcelo Garrido, Yue Shentu, Marisa Dolled‐Filhart, Ellie Im, Edward B. Garon

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

    P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment Autor Roy S. Herbst, Paul Baas, Jose Luis Pérez‐Gracia, Enriqueta Felip, Dong‐Wan Kim, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Veerle Surmont, Gilberto de Castro, Marcelo Garrido, Yue Shentu, Marisa Dolled‐Filhart, Ellie Im, Edward B. Garon

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

    Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations Autor Julien Mazières, Claire Cropet, Laure Montané, Fabrice Barlési, P.-J. Souquet, Xavier Quantin, Catherine Dubos‐Arvis, Josiane Otto, Laure Favier, Virginie Avrillon, J. Cadranel, Denis Moro‐Sibilot, I. Monnet, Virginie Westeel, J. Le Treut, Étienne Brain, Jean Trédaniel, M. Jaffro, S. Collot, G. Ferretti, Céline Tiffon, Céline Mahier‐Ait Oukhatar, Jean‐Yves Blay

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

    Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial Autor Roy S. Herbst, Paul Baas, Jose Luis Pérez‐Gracia, Enriqueta Felip, Dong‐Wook Kim, Ji‐Youn Han, Julian R. Molina, Jee Hyun Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Veerle Surmont, Gilberto de Castro, Marcelo Garrido, Yue Shentu, Kenneth Emancipator, Ayman Samkari, Erin Jensen, Gregory M. Lubiniecki, Edward B. Garon

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

    Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcin... Autor J. Guigay, Anne Aupérin, Jérôme Fayette, Esma Saâda-Bouzid, Cédrik Lafond, Miren Taberna, Lionnel Geoffrois, Laurent Martin, Olivier Capitain, Didier Cupissol, Hélène Castanie, Damien Vansteene, Philippe Schafhausen, Alison Johnson, Caroline Even, Christian Sire, Sophie Duplomb, Camille Evrard, Jean‐Pierre Delord, Brigitte Laguerre, Sylvie Zanetta, Cécile Chevassus-Clément, Aldéric Fraslin, Fanny Louat, Laura Sinigaglia, Ulrich Keilholz, Jean Bourhis, Ricard Mesı́a, Nabil Baba-Hamed, E. Babin, G. Béra, Sarah BETRIAN-LAGARDE, Emmanuel Blot, Emmanuelle Bompas, Christian Borel, Mohamed BOUCHEKOUA, L. Bozec Le Moal, Amandine Bruyas, G. Calais, Ioana Carpiuc, S. Chapet, Thierry Chatellier, Bruno Chauffert, Sandrine Pacquelet, Florian Clatot, Oana Zveltlana Cojocarasu, Alexandre CORNELLY, Alexandre Coutté, Pierre Dalloz, Franck Darloy, Melissa Delhommeau, D. De Raucourt, C. Debelleix, P. Debourdeau, Anne Françoise DILLIES-LEGRAIN, Pascal Dô, Catherine Dubos‐Arvis, Agnès Ducoulombier, Claude El Kouri, Sabrina Falkowski, François‐Régis Ferrand, Michel Gatineau, Radj Gervais, L. Gras, Pierre Guillet, Ali Hasbini, Stéphane HENAULT, Ruth Gabriela Herrera Gómez, F. Huguet, Marie Christine Kaminsky, Aurélie Lagrange, Sandrine Lavau‐Denès, H. Le Caer, Christine Le Foll, G. Lefebvre, B. Linot, Qian LOPEZ, Alain Lortholary, Margarida Matias, L. Mayache-Badis, Floriane Minne, Delphine Mollon, Eve Marie Neidhardt, J. Pavillet, Fréderic Peyrade, Yohann POINTREAU, Jean‐François Ramée, Camille RAUCHE, Sandrine Richard, Claudia Rizzo, Frédéric Rolland, Friderike SCHLURMANN, Laëtitia Stefani, Louis Tassy, Youssef Tazi, Jean‐Christophe Théry, Florida TORTI EL ZEIN, C. Toullec, Jean‐Marc Tourani, Philippe Toussaint

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: